U. AKGÖR Et Al. , "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study," International Journal of Gynecological Cancer , 2024
AKGÖR, U. Et Al. 2024. Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study. International Journal of Gynecological Cancer .
AKGÖR, U., BAŞARAN, D., Meydanli, M. M., Kuscu, E., Demirkiran, F., TOPUZ, S., ... Sancl, M.(2024). Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study. International Journal of Gynecological Cancer .
AKGÖR, UTKU Et Al. "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study," International Journal of Gynecological Cancer , 2024
AKGÖR, UTKU Et Al. "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study." International Journal of Gynecological Cancer , 2024
AKGÖR, U. Et Al. (2024) . "Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study." International Journal of Gynecological Cancer .
@article{article, author={UTKU AKGÖR Et Al. }, title={Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study}, journal={International Journal of Gynecological Cancer}, year=2024}